CAS: 1275595-86-2
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Selatinib REF: 4Z-S-226001CAS: 1275595-86-2 | - - - | To inquire | Tue 07 Jan 25 |
 | Selatinib REF: 3D-FS180427CAS: 1275595-86-2 | Min. 95% | To inquire | Thu 16 Jan 25 |
 | Lapatinib-d7 Sulfoxide Dihydrochloride REF: TR-L175812CAS: | - - - | 802.00 €~2,388.00 € | Fri 24 Jan 25 |
 | Selatinib REF: TM-T34602CAS: 1275595-86-2 | 98% | 96.00 €~1,847.00 € | Tue 25 Feb 25 |
Ref: 4Z-S-226001
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Selatinib
CAS:1275595-86-2
Selatinib is a pyridine compound that inhibits the tyrosine kinase activity of proteins. Selatinib has …
Formula:
C29H26ClFN4O3S
Purity:
Min. 95%
Molecular weight:
565.1 g/mol
Ref: 3D-FS180427
| Undefined size | To inquire |
Estimated delivery in United States, on Thursday 16 Jan 2025
Lapatinib-d7 Sulfoxide Dihydrochloride
Controlled ProductApplications Lapatinib-d7 Sulfoxide Dihydrochloride is a by-product during the synthesis of Lapatinib-d7 Dihydrochloride (L175807), a …
Formula:
C29H19D7ClFN4O3S· 2(HCl)
Color and Shape:
Neat
Molecular weight:
645.02
Ref: TR-L175812
| 25mg | 802.00 € | ||
| 50mg | 1,515.00 € | ||
| 100mg | 2,388.00 € |
Estimated delivery in United States, on Friday 24 Jan 2025
Selatinib
CAS:1275595-86-2
Selatinib is an orally active and potent dual inhibitor of EGFR and ErbB2 with anticancer …
Formula:
C29H26ClFN4O3S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
565.06
Ref: TM-T34602
| 1mg | 96.00 € | ||
| 5mg | 229.00 € | ||
| 10mg | 345.00 € | ||
| 25mg | 637.00 € | ||
| 50mg | 926.00 € |
Estimated delivery in United States, on Tuesday 25 Feb 2025
